Showing results (11-20 of 180) with videos related to
Sort By:
Pageof 18
Nuklearmedizin. Nuclear Medicine|October 1, 1992
Quantitative bone scintigraphy and 24-hour whole-body counting of 99mTc-methylene diphosphonate in patients with prostatic carcinomaG M Sundkvist, L Ahlgren, B Lilja, et al.Nuklearmedizin. Nuclear Medicine|October 1, 1993
Quantitative bone scintigraphy in prostatic carcinoma--long-term response to treatmentG M Sundkvist, L Ahlgren, B Lilja, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1985
Excretion of radionuclides in human breast milk after the administration of radiopharmaceuticalsL Ahlgren, S Ivarsson, L Johansson, et al.Archives of Environmental Health|September 1, 1986
Decrease of skeletal lead levels in man after end of occupational exposureJ O Christoffersson, L Ahlgren, A Schütz, et al.European Journal of Nuclear Medicine|January 1, 1990
Dynamic quantitative bone scintigraphy in patients with prostatic carcinoma treated by orchiectomyG M Sundkvist, L Ahlgren, B Lilja, et al.Acta Oncologica (Stockholm, Sweden)|July 27, 1999
A 252Cf-based instrument for in vivo body protein monitoring in cancer patientsL Ahlgren, M Albertsson, J Areberg, et al.American Journal of Industrial Medicine|January 1, 1984
Lead in finger-bone analysed in vivo in active and retired lead workersJ O Christoffersson, A Schütz, L Ahlgren, et al.European Journal of Nuclear Medicine|January 1, 1988
Repeated quantitative bone scintigraphy in patients with prostatic carcinoma treated with orchiectomyG M Sundkvist, L Ahlgren, B Lilja, et al.Pharmacology & Toxicology|June 1, 1991
Kinetics of lead in bone and blood after end of occupational exposureU Nilsson, R Attewell, J O Christoffersson, et al.Biological Trace Element Research|November 21, 2013
Biological monitoring, by in vivo XRF measurements, of occupational exposure to lead, cadmium, and mercuryS Skerfving, J O Christoffersson, A Schütz, et al.Pageof 18